Overview

A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, open-label study designed to determine the interaction of ketoconazole with ABT-869.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Treatments:
Ketoconazole